HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased p50/p50 NF-kappaB activation in human papillomavirus type 6- or type 11-induced laryngeal papilloma tissue.

Abstract
We have observed elevated NF-kappaB DNA-binding activity in nuclear extracts from human papillomavirus type 6- and 11-infected laryngeal papilloma tissues. The predominant DNA-binding species is the p50/p50 homodimer. The elevated NF-kappaB activity could be correlated with a reduced level of cytoplasmic IkappaBbeta and could be associated with the overexpression of p21(CIP1/WAF1) in papilloma cells. Increased NF-kappaB activity and cytoplasmic accumulation of p21(CIP1/WAF1) might counteract death-promoting effects elicited by overexpressed PTEN and reduced activation of Akt and STAT3 previously noted in these tissues.
AuthorsIvana Vancurova, Rong Wu, Veronika Miskolci, Shishinn Sun
JournalJournal of virology (J Virol) Vol. 76 Issue 3 Pg. 1533-6 (Feb 2002) ISSN: 0022-538X [Print] United States
PMID11773428 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • CDKN1A protein, human
  • Cell Extracts
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • DNA-Binding Proteins
  • I kappa B beta protein
  • I-kappa B Proteins
  • NF-kappa B
  • NF-kappa B p50 Subunit
  • Transcription Factor RelA
  • DNA
Topics
  • Cell Extracts
  • Cell Nucleus (metabolism)
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins (metabolism)
  • DNA (metabolism)
  • DNA-Binding Proteins (metabolism)
  • Dimerization
  • Humans
  • I-kappa B Proteins
  • Laryngeal Neoplasms (metabolism, pathology)
  • NF-kappa B (genetics, metabolism)
  • NF-kappa B p50 Subunit
  • Papilloma (metabolism, pathology)
  • Papillomaviridae (physiology)
  • Papillomavirus Infections (metabolism, pathology)
  • Transcription Factor RelA
  • Tumor Virus Infections (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: